106 related articles for article (PubMed ID: 1572814)
21. Design of a plastic minicolpostat applicator with shields.
Weeks KJ; Montana GS; Bentel GC
Int J Radiat Oncol Biol Phys; 1991 Sep; 21(4):1045-52. PubMed ID: 1917601
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
[TBL] [Abstract][Full Text] [Related]
23. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
24. Modeling volume effects of experimental brachytherapy in the rat rectum: uncovering the limitations of a radiobiologic concept.
Johannessen HO; Dale E; Hellebust TP; Olsen DR; Nesland JM; Giercksky KE
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):1014-22. PubMed ID: 12095571
[TBL] [Abstract][Full Text] [Related]
25. A monte carlo dosimetry study of vaginal 192Ir brachytherapy applications with a shielded cylindrical applicator set.
Lymperopoulou G; Pantelis E; Papagiannis P; Rozaki-Mavrouli H; Sakelliou L; Baltas D; Karaiskos P
Med Phys; 2004 Nov; 31(11):3080-6. PubMed ID: 15587661
[TBL] [Abstract][Full Text] [Related]
26. A novel rectal applicator for contact radiotherapy with HDR
Bellezzo M; Fonseca GP; Verrijssen AS; Voncken R; Van den Bosch MR; Yoriyaz H; Reniers B; Berbée M; Van Limbergen EJ; Verhaegen F
Brachytherapy; 2018; 17(6):1037-1044. PubMed ID: 30122346
[TBL] [Abstract][Full Text] [Related]
27. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
Mikell JK; Klopp AH; Price M; Mourtada F
Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
[TBL] [Abstract][Full Text] [Related]
28. [Rectal shielding for a Selectron-ring applicator system (HDR- and LDR-afterloading)].
Hetzel H; Kamleitner H; McCoy M; Frommhold H
Strahlenther Onkol; 1987 Dec; 163(12):782-6. PubMed ID: 3424077
[TBL] [Abstract][Full Text] [Related]
29. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
[TBL] [Abstract][Full Text] [Related]
30. Photon shielding for 241Am surface and point sources.
Courtney JC
Health Phys; 1992 Aug; 63(2):218-25. PubMed ID: 1399623
[TBL] [Abstract][Full Text] [Related]
31. [Shielded vaginal applicators for line-shaped 192Ir sources for use in the irradiation of cervix cancer].
Günther R; Walter W; Kloetzer KH; Kob D
Radiobiol Radiother (Berl); 1990; 31(4):351-9. PubMed ID: 2236523
[TBL] [Abstract][Full Text] [Related]
32. Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates.
Nath R; Bongiorni P; Rockwell S
Radiat Res; 1990 Dec; 124(3):249-58. PubMed ID: 2263725
[TBL] [Abstract][Full Text] [Related]
33. Reproducible rat model for comparing late rectal toxicity from different brachytherapy techniques.
White JR; Armour EP; Armin AR; Dewitt CC; Corry PM; Martinez A
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1155-61. PubMed ID: 9169826
[TBL] [Abstract][Full Text] [Related]
34. A three-dimensional computed tomography-assisted Monte Carlo evaluation of ovoid shielding on the dose to the bladder and rectum in intracavitary radiotherapy for cervical cancer.
Gifford KA; Horton JL; Pelloski CE; Jhingran A; Court LE; Mourtada F; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):615-21. PubMed ID: 16168853
[TBL] [Abstract][Full Text] [Related]
35. Geometric stability of intracavitary pulsed dose rate brachytherapy monitored by in vivo rectal dosimetry.
Tanderup K; Christensen JJ; Granfeldt J; Lindegaard JC
Radiother Oncol; 2006 Apr; 79(1):87-93. PubMed ID: 16546281
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of rectal shielding in a Henschke system applicator.
Howlett SJ; Denham JW; Kron T
Strahlenther Onkol; 1996 May; 172(5):265-9. PubMed ID: 8633259
[TBL] [Abstract][Full Text] [Related]
37. Cone beam CT-based three-dimensional planning in high-dose-rate brachytherapy for cervical cancer.
Al-Halabi H; Portelance L; Duclos M; Reniers B; Bahoric B; Souhami L
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1092-7. PubMed ID: 19879059
[TBL] [Abstract][Full Text] [Related]
38. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
39. The use of tetrahedral mesh geometries in Monte Carlo simulation of applicator based brachytherapy dose distributions.
Fonseca GP; Landry G; White S; D'Amours M; Yoriyaz H; Beaulieu L; Reniers B; Verhaegen F
Phys Med Biol; 2014 Oct; 59(19):5921-35. PubMed ID: 25210788
[TBL] [Abstract][Full Text] [Related]
40. Technical Note: On EM reconstruction of a multi channel shielded applicator for cervical cancer brachytherapy: A feasibility study.
Tho D; Racine E; Easton H; Song WY; Beaulieu L
Med Phys; 2018 Apr; 45(4):1673-1676. PubMed ID: 29399812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
